BBA
AGRX

Baader Bank Aktiengesellschaft’s Agile Therapeutics AGRX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-629
Closed -$5.5K – 521
2023
Q1 		$5.5K Buy
+629
New +$8.07K ﹤0.01% 358

Other funds holding AGRX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Baader Bank Aktiengesellschaft's AGRX Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Agile Therapeutics (AGRX) in Q2 2023, closing a stake of 629 shares — an estimated $5.5K sold.

Baader Bank Aktiengesellschaft first reported a position in AGRX in Q1 2023 and held it in 1 quarter. The position peaked at $5.5K in Q1 2023. 16 funds tracked by Wall St. Rank hold AGRX as of Q2 2023.

  • Baader Bank Aktiengesellschaft reported no remaining Agile Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 629 Agile Therapeutics shares in Q2 2023, an estimated $5.5K.
  • Baader Bank Aktiengesellschaft first reported a position in Agile Therapeutics in Q1 2023 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Agile Therapeutics position peaked at $5.5K in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.